Quick-blast radiation for prostate cancer shows promise in small pilot study
NCT ID NCT03486821
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested a new, shorter radiation schedule (ultra-hypofractionation) in 13 men with early-stage prostate cancer. The goal was to see if this approach causes fewer urinary side effects while still controlling the cancer. Participants had low- to intermediate-risk prostate cancer and were followed for up to 3 years to monitor side effects and cancer progression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY STAGE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kansas Medical Center/ Cancer Center
Kansas City, Kansas, 66190, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.